Not only will it efficiently control immunosuppression by MSCs and other TNFR2+ immunosuppressive cells but also angiogenesis and cell survival, highlighting its important therapeutic potential in cases like cancer treatment. This evidence concerns the gene TNFRSF1B and cancer.